TY  - JOUR
T1  - Evaluation of Intravenous Administration of Doxapram Prior to Xylazine Sedation in Camels (<i>Camelus dromedarius</i>)
AU - Almubarak, A.I. 
JO  - Journal of Animal and Veterinary Advances
VL  - 11
IS  - 23
SP  - 4455
EP  - 4459
PY  - 2012
DA  - 2001/08/19
SN  - 1680-5593
DO  - javaa.2012.4455.4459
UR  - https://makhillpublications.co/view-article.php?doi=javaa.2012.4455.4459
KW  - Camel
KW  -doxapram
KW  -xylazine
KW  -analeptic
KW  -sedation
KW  -haematology
KW  -biochemistry
AB  - The effects of doxapram on respiratory rate, heart rate, Arterial 
  Blood Pressure (ABP) and some haematology and biochemistry parameters were carried 
  out on six camels in two periods. In the first period, all camels received Intravenous 
  (IV) 0.2 mg kg<SUP>-1</SUP> xylazine while in the second period, same camels 
  received IV 0.4 mg kg<SUP>-1</SUP> doxapram, followed 10 min later by IV 0.2 
  mg kg<SUP>-1</SUP> xylazine. Cardiopulmonary measurements were taken at baseline 
  and were further recorded at 10, 20, 30, 40, 50 and 60 min after treatment in 
  both periods. Mean respiratory rate, heart rate and ABP measurements decreased 
  significantly after xylazine in the first period. Mean respiratory rate in the 
  second period increased significantly at 10 min while systolic ABP increased 
  significantly at 30 min when compared with first period. Mean heart rate decreased 
  significantly at 20 min in the second period when compared with first period. 
  There was a significant differences between the two periods in some measured 
  haematological and biochemical parameters. Doxapram was useful to increase respiratory 
  rate and ABP in xylazine sedated camels. Higher doses of doxapram needed further 
  investigation in camels.
ER  -